Chemoinformaics analysis of 10-Methoxyibogamine
| Molecular Weight | 310.441 | nRot | 2 |
| Heavy Atom Molecular Weight | 284.233 | nRig | 23 |
| Exact Molecular Weight | 310.204 | nRing | 6 |
| Solubility: LogS | -4.285 | nHRing | 4 |
| Solubility: LogP | 4.569 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 4 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 10 |
| nHA | 2 | APOL | 53.7386 |
| nHD | 1 | BPOL | 30.0994 |
| QED | 0.91 |
| Synth | 4.905 |
| Natural Product Likeliness | 0.997 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.974 |
| Pgp-sub | 0.998 |
| HIA | 0.005 |
| CACO-2 | -5.085 |
| MDCK | 0.000013 |
| BBB | 0.965 |
| PPB | 0.886245 |
| VDSS | 2.099 |
| FU | 0.0866835 |
| CYP1A2-inh | 0.944 |
| CYP1A2-sub | 0.966 |
| CYP2c19-inh | 0.671 |
| CYP2c19-sub | 0.85 |
| CYP2c9-inh | 0.234 |
| CYP2c9-sub | 0.709 |
| CYP2d6-inh | 0.932 |
| CYP2d6-sub | 0.926 |
| CYP3a4-inh | 0.4 |
| CYP3a4-sub | 0.704 |
| CL | 5.702 |
| T12 | 0.504 |
| hERG | 0.943 |
| Ames | 0.629 |
| ROA | 0.894 |
| SkinSen | 0.34 |
| Carcinogencity | 0.729 |
| EI | 0.237 |
| Respiratory | 0.943 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.644944 |